Skip to Main Content

Paper Details

Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials.
Diabetes Care
4
2022
Author NameAffiliation
Stephen E KimmelCollege of Public Health and Health Professions and College of Medicine, University of Florida
  • 1 - 1

Datasets

Release 1.2